Evidence map›Paper›PMID 33167445›Full record

ReviewDiagnostics (Basel, Switzerland)2020

Development of Diagnostic Tests for Detection of SARS-CoV-2.

Ngan N T Nguyen, Colleen McCarthy, Darlin Lantigua, Gulden Camci-Unal

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Contribution ofCurrent issues in molecular biology · 2025
    Review
  3. Article
  4. Performance assessment of a new serological diagnostic test for COVID-19 with candidate peptides from spike and nucleocapsid viral proteins.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Diagnostic techniques for COVID-19: A mini-review.Journal of virological methods · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Current trends in diagnosis and treatment strategies of COVID-19 infection.Environmental science and pollution research international · 2021
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ngan N T NguyenDepartment of Chemical Engineering, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA.
Colleen McCarthyDepartment of Chemical Engineering, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA.
Darlin LantiguaDepartment of Chemical Engineering, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA.
Gulden Camci-UnalDepartment of Chemical Engineering, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most effective ways to prevent the spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is to develop accurate and rapid diagnostic tests. There are a number of molecular, serological, and imaging methods that are used to diagnose this infection in hospitals and clinical settings. The purpose of this review paper is to present the available approaches for detecting SARS-CoV-2 and address the advantages and limitations of each detection method. This work includes studies from recent literature publications along with information from the manufacturer's manuals of commercially available SARS-CoV-2 diagnostic products. Furthermore, supplementary information from the Food & Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) is cited. The viral components targeted for virus detection, the principles of each diagnostic technique, and the detection efficiency of each approach are discussed. The potential of using diagnostic tests that were originally developed for previous epidemic viruses is also presented.

Indexed as

COVID-19diagnostic testsdisease detectionSARS-CoV-2viral infections

Identifiers

PMID33167445
PMCPMC7694548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.